- Quality and Safety: Medicines > Quality Assurance
- Quality and Safety: Medicines > Safety and Efficacy
(1995; 36 pages) [French] [Spanish]
The monitor should submit a written monitor report to the sponsor after each site visit and after all relevant telephone calls, letters and other contacts with the investigator. The report should include details of the findings and any actions taken.